Fatty liver evaluation and FibroScan in Bangkok (2026)
Tests for fatty liver assessment at Bangkok private hospitals:
- ▸Abdominal ultrasound: included in most executive check-up packages (฿8,000+); standalone ฿1,500–฿3,000 — the usual initial finding, categorises as Grade 1 (mild), Grade 2 (moderate), or Grade 3 (severe)
- ▸Liver function tests (ALT, AST, GGT, ALP, bilirubin): included in all health check-ups; ฿400–฿800 standalone — elevated ALT/AST may indicate active liver inflammation (NASH)
- ▸FibroScan (transient elastography — measures liver stiffness to estimate fibrosis stage): ฿3,000–฿6,000 at Bangkok private hospitals — the gold standard non-invasive fibrosis assessment; takes 10 minutes, completely painless; available at Bumrungrad, Samitivej, Bangkok Hospital, Vejthani
- ▸Controlled Attenuation Parameter (CAP score) — measured simultaneously with FibroScan: quantifies the degree of steatosis (fat content) accurately; ฿3,000–฿6,000 (combined with FibroScan in the same session)
- ▸Gastroenterologist / hepatologist consultation: ฿1,500–฿3,000 same-day at major Bangkok hospitals — to review ultrasound and LFT results and determine if FibroScan + metabolic work-up is needed
- ▸Metabolic panel (glucose, HbA1c, insulin resistance HOMA-IR, lipids, uric acid): ฿1,500–฿3,000 — fatty liver is closely linked to metabolic syndrome, insulin resistance, and Type 2 diabetes
- ▸Liver biopsy: ฿15,000–฿30,000 including procedure — rarely needed with FibroScan available; only for cases where FibroScan result is indeterminate or advanced fibrosis is suspected
Understanding fatty liver grades and FibroScan results
How to interpret your Bangkok ultrasound and FibroScan fatty liver findings:
- ▸Grade 1 fatty liver (mild steatosis): mild increase in liver echogenicity on ultrasound; most common finding; liver vasculature still visible; risk is low if metabolic factors controlled
- ▸Grade 2 fatty liver (moderate steatosis): moderate echogenicity increase; hepatic vessels slightly obscured; requires metabolic evaluation (HbA1c, lipids, glucose)
- ▸Grade 3 fatty liver (severe steatosis): marked echogenicity; deep hepatic vasculature not visible; requires urgent gastroenterologist consultation and FibroScan
- ▸FibroScan E value (liver stiffness in kPa): F0–F1 = no/minimal fibrosis (<7 kPa); F1–F2 = mild fibrosis (7–9.5 kPa); F2–F3 = moderate fibrosis (9.5–12.5 kPa); F3–F4 = advanced fibrosis (12.5–17.5 kPa); F4 = cirrhosis (>17.5 kPa)
- ▸CAP score (steatosis quantification): S0 <238 dB/m (no/minimal fat); S1 238–259 dB/m (mild steatosis); S2 260–292 dB/m (moderate); S3 ≥292 dB/m (severe steatosis)
- ▸NASH vs simple NAFLD: simple steatosis (fat without inflammation) is low risk; NASH (non-alcoholic steatohepatitis — fat + inflammation + ballooning) can progress to fibrosis and cirrhosis; the distinction requires FibroScan and/or biopsy
- ▸Grade 1 fatty liver with normal LFTs and no metabolic risk factors: lifestyle advice only — no medication needed; annual ultrasound recommended
- ▸Grade 2–3 fatty liver OR elevated ALT/AST OR metabolic syndrome: FibroScan + specialist consultation recommended; management of underlying risk factors essential
Fatty liver treatment in Bangkok (2026)
Management options for NAFLD/MASLD at Bangkok hospitals:
- ▸Lifestyle modification (first-line for all grades): 7–10% body weight loss reduces hepatic steatosis by 40–80%; Mediterranean diet; aerobic exercise 150 min/week; alcohol abstinence (even 'social' drinking worsens NAFLD)
- ▸GLP-1 receptor agonists (semaglutide/Ozempic, liraglutide/Victoza): now first-line evidence-based medication for MASLD with obesity — reduces liver fat 30–40% in clinical trials; also promotes weight loss; available in Bangkok at 30–50% lower cost than Western countries
- ▸Semaglutide (Ozempic injection 0.5–2mg weekly): ฿3,000–฿5,500/month in Bangkok vs $800–$1,500/month in the US
- ▸Tirzepatide (GIP/GLP-1 dual agonist — Mounjaro): ฿4,000–฿8,000/month when available in Bangkok; even more powerful for weight loss and steatosis reduction
- ▸Pioglitazone (TZD — for NASH with T2DM): ฿5–฿15/tablet; ฿150–฿450/month — reduces liver fat and fibrosis but causes water retention
- ▸Vitamin E 800 IU/day (for non-diabetic NASH): evidence for ALT reduction and histological improvement; ฿50–฿200/month
- ▸Resmetirom (Rezdiffra — THRβ agonist, FDA-approved 2024 for MASH with significant fibrosis): may be available at Bangkok hospitals on compassionate use or import — ask hepatologist
- ▸Statins: safe in fatty liver (even with mildly elevated LFTs) — atorvastatin generic ฿3–฿15/tablet; important for the cardiovascular risk that accompanies NAFLD
- ▸Management of comorbidities: control of HbA1c, blood pressure, cholesterol, weight is the most effective treatment — fatty liver is a metabolic disease